ES Therapeutics, LLC

Privately held Neumora Therapeutics, Inc. has one well-funded rival in the late-stage development of a kappa opioid receptor (KOR) antagonist for the treatment of major depressive disorder (MDD), bu

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership

Following its late 2019 merger with Aevi Genomic Medicine, Inc. , Cerecor Inc. is taking a new name – Avalo Therapeutics – and revising its therapeutic focus, having divested a pair of central nerv